HighVista Strategies’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

HighVista Strategies’s Portfolio LKFT Stock Details LKFT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-12,953	Closed	-$527K	–	139
2023 Q4	$527K	Sell	12,953 -694	-5%	-$25.5K	0.19%	115
2023 Q3	$472K	Buy	+13,647	New	+$531K	0.22%	114
2023 Q1	–	Sell	-20,701	Closed	-$919K	–	120
2022 Q4	$919K	Buy	20,701 +3,202	+18%	+$135K	0.55%	49
2022 Q3	$746K	Buy	17,499 +5,698	+48%	+$292K	0.43%	64
2022 Q2	$658K	Sell	11,801 -1,408	-11%	-$83.5K	0.4%	61
2022 Q1	$819K	Buy	+13,209	New	+$808K	0.52%	56

Other funds holding LKFT

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Finepoint Capital Boston, Massachusetts $1.95B AUM 45.61% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HighVista Strategies's LKFT Position: Q1 2024 in Review

HighVista Strategies sold out of Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q1 2024, closing a stake of 12,953 shares — an estimated $527K sold.

HighVista Strategies first reported a position in LKFT in Q1 2022 and held it in 6 quarters. The position peaked at $919K in Q4 2022. 82 funds tracked by Wall St. Rank hold LKFT as of Q1 2024.

HighVista Strategies reported no remaining Lakefront Biotherapeutics American Depositary Shares position as of Q1 2024 after selling out during the quarter.
HighVista Strategies sold 12,953 Lakefront Biotherapeutics American Depositary Shares shares in Q1 2024, an estimated $527K.
HighVista Strategies first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q1 2022 and held it in 6 quarters.
HighVista Strategies's Lakefront Biotherapeutics American Depositary Shares position peaked at $919K in Q4 2022.
82 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q1 2024.

Based on HighVista Strategies's 13F filing for Q1 2024, filed 15 May 2024.